| Document |
Document Title |
|
WO/1999/044621A1 |
Preventives/remedies for osteoporosis which contain phytoextrogen inhibiting reduction of bone density together with hardly digestible oligosaccharides. Owing to the combined use with the oligosaccharides, the effect of phytoextrogen of ...
|
|
WO/1999/043356A1 |
Methods for treating a glycolipid mediated state in a subject are described. An effective amount of at least one therapeutic compound represented by the structure A-B, in which A is a glycomimetic receptor moiety and B is an active agent...
|
|
WO/1999/041264A1 |
The invention describes an improved method for making monosialoganglioside GM3 and its intermediates. Following reaction of a neuraminic acid donor and a lactose acceotor in the presence of an acid catalyst, the $g(a) and $g(b) isomers o...
|
|
WO/1999/034812A1 |
The present invention provides a pharmaceutical composition comprising an extract or combination of extracts having an antiviral, antibacterial, or immunomodulating property, wherein the extract or combination of extracts is obtained fro...
|
|
WO/1999/033853A2 |
Derivatized carbohydrates are provided which can be used to form a variety of materials including solid delivery systems. The derivatized carbohydrates are generally carbohydrates, wherein at least a portion of the hydroxyl groups on the...
|
|
WO/1999/033540A1 |
In chromatographic separation in a plurality of steps with a chromatographic separator packed with an ion exchanger used as at least part of chromatographic packing, at least part of the ionic form of at least part of the ion exchanger i...
|
|
WO1997018222A9 |
Disclosed are novel oligosaccharide glycosides having mammalian immunosuppressive and tolerogenic properties, pharmaceutical compositions containing such oligosaccharide glycosides and methods of using such oligosaccharide glycosides to ...
|
|
WO/1999/029814A2 |
A method of preparing lipoproteins, lipoaminoacids, lipid esters, and glucolipids from olive oil or one or more of its constituting fatty acids which are condensed with vegetal protein hydrolysates or aminoacids or esterificated with alc...
|
|
WO/1999/025720A1 |
The invention relates to a carbohydrate derivative having formula (I) wherein R?1¿ is (1-4C)alkoxy; R?2¿, R?3¿ and R?4¿ are independently (1-4C)alkoxy or OSO¿3??-¿; the total number of sulfate groups is 4, 5 or 6; and the twisted l...
|
|
WO/1999/022740A1 |
The invention relates to the use of the disaccharide derivatives 3'-aminosaccharose, saccharose-C6-acid and palatinose-C6'-acid and/or an amide or alkylester thereof for preventing or treating hyperglycaemia.
|
|
WO/1999/020739A2 |
The invention concerns a lactic acid bacteria strain (1), whereof the RNA ribosome 16S is characteristic of the genus $i(Streptococcus) (2), whose profile in crude proteins, obtained after migration of crude proteins on SDS-PAGE gel elec...
|
|
WO1999000399A9 |
C-nucleosides are synthesized by a method in which a sugar is derivatized in a single step to provide a heterocycle at the C1 position, and then the heterocycle is aromatized in another single step. In one class of preferred embodiments ...
|
|
WO/1999/016777A1 |
Disclosed are novel antifungal agents having the formula (I), as well as a pharmaceutically acceptable salt, ester of prodrug thereof, wherein R is (II), or -C(O)-R¿l? wherein R¿l? is alkyl, alkenyl, aryl, arylalkenyl, aryl-aryl-, aryl...
|
|
WO/1999/011294A1 |
Methods are described for conjugating radioiodinated peptides or carbohydrate structures to proteins with improved yields and qualities of conjugates. In one method, specially designed radioiodinated bifunctional peptides containing nonm...
|
|
WO/1999/011273A1 |
A method for the inhibition of vascular smooth muscle cell hyperplasia in a human or other warm-blooded animal patient in need of such treatment, comprises administration to the patient of an effective amount of at least one sulfated oli...
|
|
WO/1999/009999A1 |
A pharmaceutical agent for treating an amyloid disease in a patient, wherein the pharmaceutical agent comprises a saccharide containing at least one substituted anionic group, or a pharmaceutically acceptable salt of the saccharide conta...
|
|
WO/1999/005158A1 |
The present invention relates to a novel and improved process for preparing 2'-fluoro-5-methyl-$g(b)-L-arabinofuranosyluridine represented by formula (1) which shows anti-viral activity, especially potent anti-viral activity against hepa...
|
|
WO/1999/005157A1 |
The present invention relates to a novel and improved process for preparing 2'-fluoro-5-methyl-$g(b)-L-arabinofuranosyluridine represented by formula (1) which shows anti-viral activity, especially potent anti-viral activity against hepa...
|
|
WO/1999/001140A1 |
The invention relates to methods for attenuating xenograft rejection in humans and old world monkeys, using oligosaccharides containing a Gal$g(a)1-3-Gal motif, to neutralize or remove anti-$g(a)Gal antibodies. The invention additionally...
|
|
WO/1998/058940A1 |
Reaction at the interface of an organic solution containing an acidic reactant and an aqueous alkaline solution containing nonreducing carbohydrates such as sucrose, sugar alcohols, cyclodextrines, and polysaccharides imparts a specifici...
|
|
WO/1998/057650A1 |
An antiathlete's foot composition characterized by comprising lactosucrose as the active ingredient. The composition is effective in the prevention and treatment of athlete's foot.
|
|
WO/1998/055513A1 |
The invention relates to new etherified carbohydrate derivatives, a method for production thereof, pharmaceutical compositions containing the same and use for the production of a pharmaceutical preparation for treatment of conditions in ...
|
|
WO/1998/054356A1 |
Process of the Spanish patent P9502185 using enzymes from various sources in order to obtain the compounds IV, V and VI which are potentially usable in the diagnostic evaluation of intestinal lactase.
|
|
WO/1998/050013A1 |
The present invention concerns a use of at least one oligosaccharide possessing from 2 to 6 glycoside residues and having a galactose residue in a non-reducing terminal position, or of a derivative of such an oligosaccharide capable of b...
|
|
WO/1998/050400A1 |
Novel acylated, hydroxyalkylated carbohydrates are described which contain 0.5-2.0 acyl groups and 0.5-4.0 hydroxyalkyl groups on positions other than anomeric positions per monosaccharide unit. A process for the preparation thereof, in ...
|
|
WO/1998/047908A1 |
Process for the preparation of lactulose from lactose wherein an aqueous solution or suspension of lactose is reacted with sodium aluminate in order to produce the isomerization of lactose to lactulose and the mixture thus obtained is ne...
|
|
WO/1998/046243A2 |
A pharmaceutical composition contains an extract obtainable from a plant of the genus $i(Trichocaulon) or $i(Hoodia) containing an appetite suppressant agent having the formula (1). A process for obtaining the extract and a process for s...
|
|
WO/1998/046246A1 |
The present invention provides novel $g(a)-O-linked glycoconjugates such as $g(a)-O-linked glycopeptides, as well as convergent methods for synthesis thereof. The general preparative approach is exemplified by the synthesis of the mucin ...
|
|
WO/1998/040512A2 |
The invention relates to a process exclusively relying on transglycolytic enzymes, for the synthesis of branched oligosaccharides. According to the described process, a donor saccharide is first incubated with an acceptor saccharide and ...
|
|
WO/1998/039347A2 |
A method for synthesizing L-ribose (1) and 2-deoxy L-ribose (12) from inexpensive D-ribose (2) is provided. The 5-$i(O)-trityl ribose (3) (prepared in 70 % yield from D-ribose) is reduced with borohydride to give the tetrol (4), which is...
|
|
WO/1998/038197A1 |
The invention provides amine-protecting groups for use in solution phase or solid-phase oligosaccharide synthesis, in which a 2-substituted 1,3-dioxo compound is used to protect one or more primary amine groups of an aminosugar or glycos...
|
|
WO/1998/034943A1 |
Surface-active amines are described having the formula (1): R?10�R?11�R?12�N?+�-CHR?2�-A?1�-R?1� wherein A?1� represents a C�7?-C�11? alkylene group; R?1� represents hydroxymethyl, carbamoyl, carboxyl or (C�1?-Cï¿...
|
|
WO/1998/034893A1 |
A novel process for producing alcohols, characterized by reacting an organic halide represented by the formula R-X (wherein R means an organic residue and X means a halogen atom) with oxygen molecules in the presence of an organotin comp...
|
|
WO/1998/034944A2 |
Process for synthesizing polyol fatty acid polyesters which includes the steps of reacting an excess of lower alkyl ester with polyol to esterify hydroxyl groups thereof and form polyol fatty acid polyester, separating at least a portion...
|
|
WO/1998/030572A1 |
Disclosed are novel synthetic processes for the preparation of the trisaccharide $g(a)Gal(1$m(7)4)$g(b)Gal(1$m(7)4)Glc-OR compounds.
|
|
WO/1998/026792A1 |
The present invention relates to compositions containing betacyanins (betanidins and betanins) and betaxanthins from antioxidant containing fruits and vegetables, preferably red beets, useful for prevention and treatment of disorders and...
|
|
WO/1998/021217A1 |
The use of oxo acids of phosphorus as the solvent enables the dissolution of difficulty soluble vegetable fibrous materials. Glucose can be prepared in a high yield by dissolving a vegetable fibrous material in a solvent comprising an ox...
|
|
WO/1998/021218A1 |
Disclosed are novel solid support matrices having a toxin-binding oligosaccharide covalently attached to a solid support through a linking arm which has at least 8 atoms separating the oligosaccharide from the solid support. The disclose...
|
|
WO/1998/019684A2 |
Disclosed is a method for producing a solid lactulose preparation from an aqueous lactulose solution in solid form as dispersing granulate, in which the aqueous lactulose solution is spray dried in a counter current, wherein said aqueous...
|
|
WO/1998/020015A1 |
Disclosed is a compound capable of releasing nitric oxide from an S-nitrosothiol group (-S-N=O), the compound comprising an S-nitrosothiol group linked via an intervening moiety, to a mono-, di- or trisaccharide moiety, wherein the mono-...
|
|
WO/1998/016536A1 |
The invention relates to a saccharide library with different saccharide-containing molecules, in which each of the molecules comprises a nuclear molecule with at least two functional groups and at least two saccharides. The invention als...
|
|
WO/1998/015544A1 |
A compound and method for producing an enantiomerically enriched epoxide from an olefin using a chiral ketone and an oxidizing agent is disclosed.
|
|
WO/1998/009976A1 |
Sulfated glycolipid derivatives having an inhibitory activity on the adhesion of selectin and represented by general formula (I) and pharmaceutically acceptable salts thereof wherein at least one of X, X�1? and X�2? represents sulfat...
|
|
WO/1998/009635A1 |
The present invention relates to a glucose-rich, mannose-containing oligosaccharide described herein having a molecular weight of approximately 1,000-5,000 daltons and is separated from interfering aloe components. The oligosaccharide in...
|
|
WO/1998/009668A2 |
Use of an amphiphilic compound in the manufacture of a medicament for the inhibition of phosphatidylcholine synthesis, said amphiphilic compound have the following properties: i) the compound copmprises a non-ionic, cationic or anionic h...
|
|
WO/1998/008548A2 |
Methods are described for conjugating radioiodinated peptides or carbohydrate structures to proteins with improved yields and qualities of conjugates. In one method, specially designed radioiodinated bifunctional peptides containing nonm...
|
|
WO/1998/008799A1 |
The invention provides a system for solid-phase synthesis of oligosaccharides, based on the discovery that a 2-substituted-1,3-dioxocycloalkyl linker group of general formula (I) can be used to couple saccharide groups of both the O-glyc...
|
|
WO/1998/006730A1 |
Derivatives of sialyl-Lewis X and A, in which the natural neuraminic acid residue and the natural N-acetylglucosamine monomer are replaced.
|
|
WO/1998/005793A1 |
The invention concerns a method for preparing a polydispersed saccharide composition poor in glucose (G), fructose (F) and saccharose (GF) containing at least 93.5 % by weight per dry matter of fructo- oligosaccharides constituted by a c...
|
|
WO/1998/004272A1 |
Mannose-containing, branched oligosaccharides mediate binding of chlamydia to mammalian cells. The 'high mannose-type' glycan was found to block adhesion of chlamydiae to mammalian cells and thus to inhibit infectivity. The glycan and it...
|
